D57.814
BillableOther sickle-cell disorders with dactylitis
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is D57.814 an HCC code?
Yes. D57.814 maps to Sickle Cell Disorders and Thalassemia under the CMS-HCC V28 risk adjustment model (and Severe Hematological Disorders under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for D57.814
For D57.814 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed D57.814 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
D57.814 is the ICD-10-CM diagnosis code for other sickle-cell disorders with dactylitis. A rare sickle-cell disorder with dactylitis, which is severe pain and swelling in the hands and feet. D57.814 sits in the ICD-10-CM chapter for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (d50-d89), within the section covering hemolytic anemias (d55-d59).
Under the CMS-HCC V28 risk adjustment model, D57.814 maps to Sickle Cell Disorders and Thalassemia (HCC 108) with a community, non-dual, aged base RAF weight of 0.607. Under the older CMS-HCC V24 model, D57.814 maps to Severe Hematological Disorders (HCC 46) with a community, non-dual, aged base RAF weight of 0.666. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Dactylitis is often one of the first manifestations of sickle-cell disease in children; verify documentation of hand/foot involvement. Because D57.814 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for D57.814 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Dactylitis is often one of the first manifestations of sickle-cell disease in children; verify documentation of hand/foot involvement
- •Ensure the swelling and pain are specifically attributed to sickle-cell disease rather than other causes
Clinical Significance
Other sickle-cell disorders with dactylitis describes painful vaso-occlusive crises affecting the small bones of the hands and feet in patients with rare sickle-cell variants. Dactylitis (hand-foot syndrome) is often the earliest clinical manifestation of sickle-cell disease in infants and young children, typically presenting between 6 months and 2 years of age. The condition causes symmetric painful swelling of the digits and can lead to permanent bone damage if recurrent.
Documentation Requirements
- ✓Document the specific sickle-cell variant and clinical findings of hand and/or foot swelling with pain.
- ✓Include radiographic findings if obtained, showing soft tissue swelling or periosteal reaction.
- ✓Record patient age at presentation, symptom duration, and response to treatment.
- ✓Document any prior episodes of dactylitis and evidence of bone changes from recurrent episodes.
Commonly Confused Codes
- •D57.04 (Hemoglobin SS disease with dactylitis) is for homozygous sickle-cell disease specifically.
- •D57.214 (Sickle-cell/hemoglobin C disease with dactylitis) applies to the hemoglobin SC variant.
- •D57.414/D57.454 covers sickle-cell thalassemia variants with dactylitis.
- •M89.8x (Other specified disorders of bone) should not be used when the cause is clearly sickle-cell dactylitis.